From a margin perspective, Danaher's operations should eventually improve once top-line growth rebounds. With that operating leverage-related margin expansion, we expect Danaher's adjusted EPS to grow ...
aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond. This press release features multimedia. View the full release here: https ...
The Bureau of Industry and Security is placing new export controls on certain laboratory equipment that can be used for biotechnology purposes that may threaten U.S. national security, the agency said ...
On the 15th local time, the U.S. Department of Commerce announced export control regulations requiring government authorization for exporting certain equipment used in biotechnology laboratories.
The US Department of Commerce (DOC) announced new export controls on biotech equipment and related technology in light of national security concerns regarding AI and data science, according to ...